Hsbc Holdings PLC Cara Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

  • $168 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$15.07 - $21.71 $194,222 - $279,798
-12,888 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$12.72 - $16.16 $163,935 - $208,270
12,888 New
12,888 $194,000
Q3 2020

Nov 12, 2020
SELL
$12.34 - $17.92 $176,437 - $256,220
-14,298 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$12.39 - $17.33 $177,152 - $247,784
14,298 New
14,298 $244,000

Others Institutions Holding CARA

# of Institutions
65
Shares Held
12.7M
Call Options Held
0
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $260M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email